Authors of a new study found that estradiol levels can be used to predict fracture risk among women during the menopausal transition.
Treatment of Vasomotor Symptoms: From Hormone Therapy to Neurokinin Receptor Antagonists
Larkin Larkin, MD, reviews treatment options for VMS, comparing hormone therapy effectiveness with antidepressants and new neurokinin antagonists.
Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and Cardiovascular Outcomes
Today's episode covers depression risk after chronic illness, vaginal estradiol safety, GLP-1 updates, cancer risk, and cardiovascular outcomes.
Donna Plecha, MD: How to Talk to Women About Dense Breasts and Supplemental Breast Cancer Screening
Breast imaging expert, Donna Plecha, MD, provides a roadmap for primary care physicians to implement risk assessment tools and high-risk clinic referrals in their practice.
Weekly Dose Podcast: CRC Screening Uptake, GLP-1 Eligibility in Youth, Women’s Heart Health, and Ultraprocessed Food Risks
This week’s podcast episode covers CRC screening, GLP-1 eligibility in youth, women’s heart health, FIT outreach, and ultraprocessed food risks.
High Ultra-Processed Food Intake Linked to Increased Risk of Early-Onset Colorectal Adenomas in Women
New research links high ultra-processed food intake to increased risk of precursors for early-onset colorectal cancer in women under 50.
Hormone Replacement Therapy After the WHI: Clinician’s Evidence Timeline (2002–2025)
The comprehensive timeline highlights how WHI findings and subsequent research reshaped HRT risk assessment, guidance, and FDA labeling through 2025.